Be Armed and Ready – the Asymmetrical Battlefield Could Be Here at Home
CBS News Reporter Went Nuts Over This Photo of Susie Wiles in the...
Women’s Sports Just Aren’t As Entertaining As Men’s Are
Pete Hegseth, Vindicated (Part Deux)
Punctuated Living
The New American Century
The Law
The Left Is Petrified That Trump Will Succeed in Iran and Expose Them...
'Hanoi' Jane Typifies Hollywood Idiocy
FDA Cruelly Holding Up Approval of Treatments for Rare Diseases, Despite Children Likely...
10 Reported Dead After Pakistanis Attempt to Storm U.S. Embassy
Trump Calls on Iranian Military to Lay Down Arms or Face Certain Death
Thomas Massie Joins in With Democrat Allies Who Claim That Iran Strikes Are...
Miami Man Gets 4.5 Years in Prison for Possessing 450 Stolen or Counterfeit...
Illegal Immigrant Sentenced to 19 Years Over Alleged $4M Romance, Business Scams
Tipsheet

Moderna Announces Development of Combination COVID-19 Booster and Flu Vaccine

Moderna Announces Development of Combination COVID-19 Booster and Flu Vaccine
AP Photo/Rogelio D. Solis

Moderna announced on Thursday it had begun development for a potential single-dose vaccine that is a combination of a Wuhan coronavirus vaccine booster shot and seasonal flu shot. 

Advertisement

In a press release published Thursday, Moderna CEO Stephane Bancel announced the new development and shared the progress of other programs the company is working on, such as their “cancer vaccine.” 

“Today we are announcing the first step in our novel respiratory vaccine program with the development of a single dose vaccine that combines a booster against COVID-19 and a booster against flu,” Bancel said in a statement. “We are making progress on enrolling patients in our rare disease programs, and we are fully enrolled in our personalized cancer vaccine trial. We believe this is just the beginning of a new age of information-based medicines.”

As we previously reported, Moderna informed investors and analysts last month that the company was planning for a booster COVID-19 shot in addition to its already-existing two-dose mRNA vaccine shot. As of right now, the Moderna COVID-19 vaccine was granted Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA) to be administered to prevent the spread of COVID-19. However, the vaccine has not been fully approved by the FDA.

Advertisement

Related:

COVID-19 VACCINE

“We are pleased that our COVID-19 vaccine is showing durable efficacy of 93% through six months, but recognize that the Delta variant is a significant new threat so we must remain vigilant,” Bancel said in a statement last month announcing plans for a potential booster shot. In the statement, Bancel also said Moderna is “looking forward towards our vision of a single dose annual booster that provides protection against COVID-19, flu and RSV for adults.”

Perhaps that vision could be on the horizon with this hybrid coronavirus/flu vaccine in the works. This week, however, World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus reiterated his call for a halt on COVID-19 booster shots through the end of the year. Moderna has not revealed when it plans to have the booster shot completed.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos